Key result
N-acetylprocainamide depresses dP/dt at /min and lacks positive inotropic activity in ischemic rabbit hearts.
Why the study?
Does N-acetylprocainamide have intrinsic direct positive inotropic activity compared to procainamide in ischemic isolated rabbit hearts?
Does N-acetylprocainamide have intrinsic direct positive inotropic activity compared to procainamide in ischemic isolated rabbit hearts?
N-acetylprocainamide does not possess intrinsic direct positive inotropic activity in the isolated ischemic rabbit heart model, and its apparent inotropic effects at low doses are likely catecholamine-mediated.
Answers are grounded in this paper and cite their sources.
Lacks direct inotropic activity in ischemic rabbit hearts; leaves open catecholamine-mediated effects for in vivo study.
While many antiarrhythmic drugs depress myocardial function, N-acetylprocainamide, the major metabolite of procainamide, appears to improve myocardial performance in vivo. The present study compared the effect of procainamide with N-acetylprocainamide on the isolated, perfused, globally ischemic rabbit heart. Procainamide depressed dPldt at infusion rates of 2 mg/min or greater. N-Acetylprocainamide depressed dP/dt at infusion rates of 40 mg/min or greater and may have increased dP/dt at low rates of around 1 mg/min. Pretreatment of the rabbits with reserpine abolished any increase in dPldt produced by N-acetylprocainamide. We conclude that N-acetylprocainamide does not have intrinsic direct positive inotropic activity in this model.
No takes yet. Share an insight, caveat, or question.
Kluger et al. (1981) studied Ischemic isolated rabbit hearts. Procainamide and N-Acetylprocainamide was evaluated on Myocardial contractility (dP/dt). N-acetylprocainamide depressed dP/dt at infusion rates ≥/min and lacks intrinsic direct positive inotropic activity in isolated ischemic rabbit hearts.
Synapse has enriched 10 related papers. Consider them for comparative context: